<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We tested the hypothesis that inhibiting nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> production either before or during transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> affects early postischemic brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:chebi fb="2" ids="5615">Halothane</z:chebi>-anesthetized cats underwent 1 hour of left middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> plus 3 hours of reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Pretreatment groups received either intravenous N omega-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>; 10 mg/kg, n = 10) or an equal volume of diluent (10 mL saline, n = 10) over 30 minutes before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Posttreatment groups received intravenous L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> (10 mg/kg) over 30 minutes from 45 minutes of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> to 15 minutes of reperfusion (n = 10) or intravenous L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> (10 mg/kg) plus <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (200 mg/kg) over the same period followed by continuous <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> infusion (200 mg/kg per hour) for the remainder of reperfusion (n = 10) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Microsphere-determined blood flow to ipsilateral caudate nucleus and inferior temporal cortex decreased to the same extent during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and recovered to the same extent during reperfusion in the four groups </plain></SENT>
<SENT sid="5" pm="."><plain>Triphenyltetrazolium-determined injury volume of ipsilateral caudate nucleus in cats treated with L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> before or during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (42 +/- 7% and 42 +/- 3% of caudate nucleus, respectively; mean +/- SE) was less (P &lt; .05) compared with that in cats pretreated with saline (72 +/- 5%) or cats treated with L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> plus <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (68 +/- 5%) </plain></SENT>
<SENT sid="6" pm="."><plain>Ipsilateral cerebral hemispheric injury volume was similar among the four groups (23 +/- 5%, 13 +/- 3%, 18 +/- 5%, and 29 +/- 5% of hemisphere in groups treated with L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the saline-treated group, and the group treated with L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> plus <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi>, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Inhibition of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase decreases caudate injury volume from transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in cats </plain></SENT>
<SENT sid="8" pm="."><plain>The beneficial effect is reversed by <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> and is not caused by favorable redistribution of blood flow during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion </plain></SENT>
<SENT sid="9" pm="."><plain>Because L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> was efficacious when administered at reperfusion, nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> generated during reperfusion appears to contribute to caudate injury </plain></SENT>
</text></document>